Moreover, recent pan-cancer analyses of almost 10,000 adult and 1600 pediatric cancers further demonstrate the significance of ARID1A mutations in multiple malignancies (Bailey et al. 2018; Gröbner et al. 2018; Ma et al. 2018). Here, ARID1A is linked to cancer.